Status:
RECRUITING
Parasternal Blockade and Serum Lactate in Cardiac Surgery
Lead Sponsor:
Instituto Mexicano del Seguro Social
Conditions:
Elective Cardiac Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcome...
Detailed Description
Background: Serum lactate level is a crucial indicator of tissue perfusion. Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress...
Eligibility Criteria
Inclusion
- Adult patients older than 18 years
- Either sex
- ASA II-III
- Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.
Exclusion
- Patients with pre-existing conditions that could independently affect serum lactate levels.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06516432
Start Date
January 1 2024
End Date
December 31 2024
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Médico Nacional de Occidente
Guadalajara, Jalisco, Mexico, 44329